TEVJF

Teva Pharmaceutical Industries Limited OTC

Healthcare ·Drug Manufacturers - Specialty & Generic ·IL · tevapharm.com

$29.19

Mkt Cap $34.0B

52w Low $13.73 66.4% of range 52w High $37.00

50d MA $28.68 200d MA $20.12

P/E (TTM) 23.7x

EV/EBITDA 14.6x

P/B 4.6x

Debt/Equity 2.2x

ROE 19.0%

P/FCF 14.2x

RSI (14) —

ATR (14) —

Beta 0.89

50d MA $28.68

200d MA $20.12

Avg Volume 10

About

Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage forms, including tablets, capsules, injectables, inhalant…

Recent Earnings

Date	Time	Est	Rptd	Surp	Base	Gap%	D1%	D2%	D3%	D4%	D5%	Guide ▲★
Apr 29, 2026	TNS	0.45	0.50	+10.3%	29.19	+0.0%	+0.0%	+0.0%	—	—	—	—
Jan 28, 2026	TNS	0.64	0.93	+46.2%	28.36	+0.0%	+0.0%	+0.0%	+0.0%	+0.0%	+0.0%	—
Jul 30, 2025	TNS	0.62	0.24	-60.6%	14.00	+0.0%	+0.0%	+0.0%	+0.0%	+0.0%	+0.0%	—
May 7, 2025	TNS	0.46	0.18	-59.5%	16.11	+0.0%	+0.0%	+0.0%	+0.0%	+0.0%	+0.0%	—
Jan 29, 2025	TNS	0.70	-0.19	-127.5%	19.03	-2.8%	-2.8%	-2.8%	-2.8%	-2.8%	-2.8%	—
Nov 6, 2024	TNS	0.66	-0.39	-158.1%	17.00	+0.0%	+0.0%	+0.0%	+0.0%	+5.9%	+5.9%	—
Jul 31, 2024	TNS	0.54	-0.74	-237.5%	17.50	+0.0%	-8.6%	-12.7%	-14.3%	-14.3%	-14.3%	—
May 8, 2024	TNS	0.52	-0.12	-123.6%	—	—	—	—	—	—	—	—
Jan 31, 2024	TNS	0.79	0.38	-52.1%	12.99	+0.0%	+0.0%	+0.0%	+0.0%	+0.0%	+0.0%	—
Nov 9, 2023	TNS	0.62	0.07	-88.7%	8.50	+2.0%	+2.0%	+2.0%	+2.0%	+2.0%	+2.0%	—
Aug 2, 2023	TNS	0.52	-0.77	-247.9%	8.04	+0.0%	+0.0%	+0.0%	+18.7%	+18.7%	+18.7%	—
May 10, 2023	TNS	0.56	-0.21	-138.6%	8.35	+0.0%	+0.0%	+0.0%	+0.0%	+4.1%	+4.1%	—

Recent Analyst Ratings

Date	Firm	Action	Grade	Target	Base	Open	Gap%	D1%	D2%	D3%	D4%	D5%
Sep 19	UBS	Maintains	Neutral → Neutral	—	$10.25	$10.25	+0.0%	+0.0%	+0.0%	+0.0%	+0.0%	+0.0%
Sep 7	BofA Securities	Maintains	Buy → Buy	—	$8.91	$8.91	+0.0%	+0.0%	+0.0%	+0.0%	+12.2%	+15.0%
Jul 5	UBS	Upgrade	Sell → Neutral	—	—	—	—	—	—	—	—	—
May 25	Morgan Stanley	Maintains	Equal Weight → Equal Weight	—	$8.10	$7.50	-7.4%	-7.4%	-10.5%	-10.5%	-10.5%	-10.5%
May 17	Evercore ISI	Upgrade	In Line → Outperform	—	$8.69	$8.69	+0.0%	+0.0%	+0.0%	+0.0%	-6.8%	-6.8%
May 10	BofA Securities	Maintains	Buy → Buy	—	$8.35	$8.35	+0.0%	+0.0%	+0.0%	+0.0%	+0.0%	+4.1%
Feb 8	Barclays	Maintains	Overweight → Overweight	—	$9.86	$9.86	+0.0%	+0.0%	+0.0%	+0.0%	+0.0%	+0.0%
Jan 18	Jefferies	Downgrade	Buy → Hold	—	$12.73	$9.67	-24.0%	-24.0%	-24.0%	-24.5%	-24.5%	-24.5%
Nov 22	Piper Sandler	Maintains	Underweight → Underweight	—	$8.70	$8.70	+0.0%	+0.0%	+0.0%	+0.0%	+0.0%	+0.0%
Nov 13	JP Morgan	Downgrade	Neutral → Underweight	—	—	—	—	—	—	—	—	—
Nov 7	BMO Capital	Maintains	Market Perform → Perform	—	$8.70	$8.70	+0.0%	+0.0%	+0.0%	+0.0%	+0.0%	+0.0%
Nov 6	BMO Capital	Maintains	Market Perform → Market Perform	—	—	—	—	—	—	—	—	—
Aug 4	BofA Securities	Upgrade	Neutral → Buy	—	$9.80	$9.61	-1.9%	-1.9%	-1.9%	+13.1%	+21.9%	+12.2%
Aug 1	Goldman Sachs	Maintains	Neutral → Neutral	—	$9.00	$9.00	+0.0%	+0.0%	+8.9%	+8.9%	+6.8%	+6.8%
Jun 14	UBS	Maintains	Neutral → Neutral	—	$8.35	$8.35	+0.0%	+0.0%	+0.0%	+0.0%	+0.0%	+0.0%
May 16	BofA Securities	Upgrade	Underperform → Neutral	—	$8.07	$8.43	+4.5%	+4.5%	+4.5%	+4.5%	+4.5%	+4.5%
May 11	Goldman Sachs	Maintains	Neutral → Neutral	—	$8.07	$8.07	+0.0%	+0.0%	+0.0%	+0.0%	+4.5%	+4.5%
May 3	Piper Sandler	Downgrade	Neutral → Underweight	—	$9.00	$9.00	+0.0%	+0.0%	+0.0%	-11.1%	-10.3%	-10.3%
Apr 4	Barclays	Upgrade	Equal Weight → Overweight	—	$9.22	$9.22	+0.0%	+0.0%	+0.0%	+0.0%	+0.0%	+0.0%
Feb 17	Barclays	Maintains	Equal Weight → Equal Weight	—	$8.18	$8.18	+0.0%	+0.0%	+0.0%	+0.2%	+0.2%	-2.2%
Jan 26	Argus	Downgrade	Buy → Hold	—	$8.43	$8.43	+0.0%	+0.0%	+0.0%	+0.0%	+0.0%	+0.0%
Oct 28	Raymond James	Downgrade	Outperform → Perform	—	$9.81	$9.81	+0.0%	+0.0%	+0.0%	+0.0%	+3.4%	+3.4%
Oct 27	Raymond James	Downgrade	Outperform → Market Perform	—	$9.81	$9.81	+0.0%	+0.0%	+0.0%	+0.0%	+0.0%	+3.4%
Jul 28	Wells Fargo	Maintains	Equal Weight → Equal Weight	—	$9.56	$9.99	+4.5%	+4.8%	+4.8%	-0.6%	-0.6%	-0.6%
Jul 28	Raymond James	Maintains	Outperform → Outperform	—	$9.56	$9.99	+4.5%	+4.8%	+4.8%	-0.6%	-0.6%	-0.6%
May 3	UBS	Downgrade	Buy → Neutral	—	$10.40	$10.40	+0.0%	+0.0%	-0.8%	-0.8%	+1.0%	+1.0%
Nov 25	Oppenheimer	Maintains	Perform → Perform	—	$9.25	$9.25	+0.0%	+0.0%	+0.0%	+4.1%	+4.1%	+4.1%
Nov 6	BMO Capital	Maintains	Market Perform → Perform	—	$9.00	$8.52	-5.3%	+3.3%	+3.3%	+3.3%	+0.9%	+0.9%
Nov 5	BMO Capital	Maintains	Market Perform → Market Perform	—	$9.00	$9.00	+0.0%	+0.0%	+3.3%	+3.3%	+3.3%	+0.9%
Aug 6	SVB Leerink	Maintains	Market Perform → Perform	—	$13.20	$13.25	+0.4%	+0.4%	+0.4%	-9.1%	-9.1%	-1.6%
Aug 5	Barclays	Upgrade	Underweight → Equal Weight	—	$11.05	$13.20	+19.5%	+19.5%	+19.9%	+19.9%	+8.6%	+8.6%
Aug 5	SVB Leerink	Maintains	Market Perform → Market Perform	—	$11.05	$13.20	+19.5%	+19.5%	+19.9%	+19.9%	+8.6%	+8.6%
May 31	SunTrust Robinson Humphrey	Upgrade	Hold → Buy	—	—	—	—	—	—	—	—	—
May 10	UBS	Maintains	Buy → Buy	—	—	—	—	—	—	—	—	—
May 7	SVB Leerink	Maintains	Market Perform → Market Perform	—	$10.00	$10.00	+0.0%	+12.3%	+14.5%	-10.0%	+17.1%	+1.5%
Apr 14	Piper Sandler	Maintains	Neutral → Neutral	—	$12.00	$12.00	+0.0%	-22.8%	-18.3%	-12.8%	-15.4%	-12.5%
Apr 5	UBS	Upgrade	Neutral → Buy	—	—	—	—	—	—	—	—	—
Apr 1	Morgan Stanley	Maintains	Underweight → Underweight	—	$9.00	$10.00	+11.1%	-2.8%	-10.0%	-11.1%	-4.4%	+2.2%
Mar 22	BofA Securities	Maintains	Underperform → Underperform	—	—	—	—	—	—	—	—	—
Mar 4	Wells Fargo	Maintains	Equal Weight → Equal Weight	—	$13.60	$13.60	+0.0%	+0.0%	+0.0%	+0.0%	-4.4%	-4.4%
Feb 17	Argus	Maintains	Buy → Buy	—	—	—	—	—	—	—	—	—
Feb 13	Morgan Stanley	Maintains	Underweight → Underweight	—	$13.20	$12.95	-1.9%	-1.9%	-6.1%	-6.1%	-1.1%	-1.1%
Feb 12	SunTrust Robinson Humphrey	Maintains	Hold → Hold	—	$8.50	$13.50	+58.8%	+55.3%	+52.4%	+45.9%	+45.9%	+53.5%
Feb 12	BofA Securities	Maintains	Underperform → Underperform	—	$8.50	$13.50	+58.8%	+55.3%	+52.4%	+45.9%	+45.9%	+53.5%
Feb 12	Oppenheimer	Maintains	Outperform → Outperform	—	$8.50	$13.50	+58.8%	+55.3%	+52.4%	+45.9%	+45.9%	+53.5%
Feb 11	CFRA	Maintains	Hold → Hold	—	$11.98	$8.50	-29.0%	-29.0%	+10.2%	+8.1%	+3.5%	+3.5%
Feb 11	Cantor Fitzgerald	Maintains	Neutral → Neutral	—	$11.98	$8.50	-29.0%	-29.0%	+10.2%	+8.1%	+3.5%	+3.5%
Jan 21	Wells Fargo	Maintains	Equal Weight → Equal Weight	—	$10.35	$10.35	+0.0%	+0.0%	+0.0%	+0.0%	+0.0%	+0.0%
Nov 11	JP Morgan	Upgrade	Underweight → Neutral	—	$6.56	$6.56	+0.0%	+0.0%	+0.0%	+0.0%	+52.1%	+49.4%
Nov 7	Piper Sandler	Maintains	Neutral → Neutral	—	$6.56	$6.56	+0.0%	+0.0%	+0.0%	+0.0%	+0.0%	+0.0%

Recent Filings

8-K · 7.01 ! Medium

Teva Pharmaceutical Industries Ltd -- 8-K 7.01: Regulation FD Disclosure

Teva Pharmaceutical agreed to acquire Emalex Biosciences in a definitive deal announced April 29, 2026, expanding its biopharmaceutical portfolio through this strategic acquisition.

Apr 29

Data updated apr 27, 2026 7:51pm · Source: massive.com